Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India

Posted On: 2021-01-12 03:53:08 (Time Zone: Arizona, USA)


Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the independent Data and Safety Monitoring Board (DSMB) has reviewed the safety data from the phase 2 clinical trial of the Sputnik V vaccine and recommended the phase 3 recruitment and continue the clinical trial without any modifications.

The phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India. The DSMB concluded that no safety concerns were identified and the study has met the primary endpoints of safety. Further, the safety data has been submitted to the Drugs Controller General of India (DCGI) for review and approval to continue phase 3 clinical trials.

G V Prasad, Co-chairman and Managing Director, Dr. Reddy's Laboratories said, "The Indian clinical trial being conducted by Dr. Reddy's and RDIF is an adaptive design phase 2/3 trial. It is a bridging study to the larger global phase 3 study on 31,000 subjects. The phase 2 study in India showed a very good safety profile. This further reinforces our confidence in the safety of Sputnik V, which has now been administered to more than 1 million people in Russia and more than 300,000 people in Argentina. We are working closely towards fast-tracking the launch of the Sputnik V vaccine in India."

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, "The safety data from the phase 2 clinical trial from India is very positive, and confirms the safety profile of Sputnik V in the international markets. The Sputnik V consistently shows safety and high efficacy in international clinical trials as it is based on safe human adenoviral vector platform."

The clinical trials are being conducted by JSS Medical Research as the clinical research partner in India. Dr. Reddy's has partnered with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT) for advisory support, THSTI (Translational Health Science and Technology Institute) for further immunogenicity data characterisation, and to use BIRAC's clinical trial centres for the vaccine.

In September 2020, Dr. Reddy's and Russian Direct Investment Fund (RDIF) entered into a partnership to conduct the clinical trials of the Sputnik V vaccine and the rights for distribution in India.

Sputnik V developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world's first registered vaccine against COVID-19 based on the established human adenoviral vector platform. It currently ranks among top 10 candidate vaccines approaching the end of clinical trials and the start of mass production on the World Health Organization's (WHO) list. The vaccine's efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials in Russia. Currently, the vaccine's clinical trials are underway in the UAE, Egypt, Venezuela and Belarus while it has been registered in Algeria, Argentina, Belarus, Bolivia and Serbia for inoculation.

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.5403.95 as compared to the previous close of Rs. 5337.3. The total number of shares traded during the day was 27806 in over 2857 trades.

The stock hit an intraday high of Rs. 5425.5 and intraday low of 5328.9. The net turnover during the day was Rs. 150081592.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Can Fin Homes Ltd Q3 FY2020-21 net profit up at Rs. 131.91 crore

Genus Paper & Boards Ltd Q3FY21 net profit at Rs. 4.15 crore

Chennai Petroleum Corporation Ltd Q3FY21 consolidated loss at Rs. 546.41 crore

Sharda Cropchem Ltd Q3FY21 consolidated PAT jumps to Rs. 48.30 crore

Natural Capsules Ltd reports consolidated PAT of Rs. 1.62 crore in Q3FY21

TGV Sraac Ltd reports lower Q3FY21 net profit of Rs. 9.85 crore

Aarti Drugs Ltd Q3FY21 consolidated PAT drops QoQ to Rs. 68.04 crore

Lakshmi Electrical Control Systems Ltd Q3FY21 net profit at Rs. 0.0875 crore

PG Electroplast Ltd Q3FY21 net profit rises to Rs. 6.49 crore

Kirloskar Ferrous Industries Ltd Q3 net profit jumps to Rs. 118.32 crore

Stylam Industries Ltd reports Rs. 12.46 crore consolidated PAT in Q3FY21

Vinyl Chemicals India Ltd posts Rs. 4.83 crore PAT in Q3 FY2020-21

APL Apollo Tubes Ltd Q3FY21 consolidated PAT higher at Rs. 132.04 crore

Thomas Cook India inks strategic agreement with Destination Maldives

PNC Infratech Limited receives LOAs for Six New Rural Drinking Water Supply Projects on EPC mode for an aggregate value of Rs. 2475.00 crore

Arihant Capital Markets Ltd posts consolidated PAT of Rs. 8.94 crore in Q3FY21

Kotak Mahindra Bank posts Rs. 2575.74 crores consolidated PAT in Q3 FY2020-21

Shri Jagdamba Polymers Ltd Q3 net profit jumps to Rs. 11.35 crore

UCO Bank Q3FY21 PAT at Rs. 35.44 crore

DCW Limited board approves fund raising through warrants

Lupin Receives approval for Sevelamer Carbonate Tablets

Strides receives USFDA approval for Ursodiol Capsules

Kiri Industries Limited starts commercial production of Specialty Intermediates at Vadodara Palnt

Bannari Amman Spinning Mills Ltd board approves stock split, CDR

Padget Electronics to commence manufacturing of Nokia smartphones as HMD Global's manufacturing partners

Zydus' Desidustat shows efficacy and safety in treating Hypoxia in hospitalized Covid-19 patients in Mexico

Wipro recognised as Top Employer 2021 in Australia for the second consecutive year

Antony Waste Handling Cell Ltd updates on business during Q3 FY21

Tiaan Consumer Limited Signs Up as a Beauty Partner for Safe Speed Challenge

R S Software India Ltd posts loss of Rs. 5.11 crore in Q3FY21

NCL Industries Ltd to set up 2000 TPD cement grinding unit

Riba Textiles Limited to expand capacity

United Spirits Limited to sell its stake in Tern Distilleries Pvt Ltd for Rs. 30 crore

Hinduja Global Solutions Limited arm raises stake in HGS Digital LLC to 100%

Adani Green Energy Signs Agreement to Acquire 20 MW Operating Solar Asset for INR 133 cr

Steel Exchange India Limited receives OTS sanction letters from all lenders

DCB Bank Ltd posts Q3FY21 net profit of Rs. 96.21 crore

Vivanza Biosciences Ltd posts consolidated PAT of Rs. 0.16 crore in Q3

Arihant Superstructures Ltd Q3FY21 consolidated net profit at Rs. 1.94 crore

ICRA reaffirms rating of IIFL Finance Ltd, IIFL Home Finance Ltd

Zenotech Laboratories Ltd appoints Mr. Devendra Chandrakant S. Kenkre as CEO

Polycab India Ltd reports Q3FY21 consolidated PAT of Rs. 262.50 crore

JM Financial Ltd posts consolidated PAT of Rs. 180.76 crore in Q3 FY2020-21

Birla Corporation Ltd Q3FY21 consolidated PAT at Rs. 148.42 crores

Sportking India Ltd Q3 net profit zooms to Rs. 30.32 crore

APM Finvest Ltd Q3FY21 net profit jumps to Rs. 6.90 crore

Ultratech Cement Ltd reports jump in Q3FY21 consolidated PAT to Rs. 1584.34 crores

Supreme Industries Ltd Q3FY21 Q3FY21 consolidated PAT zooms to Rs. 312.28 crore

Mahindra Lifespaces achieves residential sales of Rs. 195 crores during Q3FY21 up 70% over Q2FY21

Rossari Biotech Ltd Q3FY21 consolidated PAT up at Rs. 21.60 crore



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020